Anticardiolipin antibody of adolescents and age of myocardial infarction in parents

Medical Science Monitor

Volumn 9, Issue 12, 2003, Pages

  Kelishadi, Roya ^a   Sabet, Babak ^a   Khosravi, Alireza ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adolescents; Anticardiolipin antibody; High risk families; Premature myocardial infarction

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PROGENY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, ANTICARDIOLIPIN; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARENTS; RISK FACTORS;

EID: 17944395292     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lavy PJ, Gonzalez MF, Hornung CA: A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis. J Vasc Surg, 1996; 23: 36-45
2. Harris LM, Peer R, Curl GR: Long term follow up of patients with early atherosclerosis. J Vasc Surg, 1996; 23: 576-81
3. Vaarala O, Alfthan G, Jauhiainen M: Cross reaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematous. Lancet, 1993; 2: 923-5
4. Hasunuma Y, Matsuura E, Makita Z: Involvement of alfa2-glycoprotein uptake by macrophages. Clin Exp Immunol, 1997; 107: 569-74
5. Shoenfeld Y, Harats D, George J: Atherosclerosis and antiphospholipid syndrome: a link unrevealed? Lupus, 1998; 7(Suppl 2): S 140-3
6. Vaarala O, Manttari M, Manninen V: Anticardiolipin antibodies and risk of myocardial infarction in a prospective-cohort of middle-aged men. Circulation, 1995; 91: 23-7
7. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology, 1993; 43: 2069-73
8. Zuckerman E, Toubi E, Shiran A et al: Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: A controlled prospective study. Am J Med, 1996; 100: 381-5
9. Holman R, McGill HC, Strong JP, Geer J C: The natural history of atherosclerosis: The early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J pathol, 1958; 34: 209-35
10. Williams CL, Hayman LL, Daniels SR et al: Cardiovascular Health in childhood. A Statement for Health Professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 2002; 106: 143- 60
11. Ucar B, Kilic Z, Sonmez HM et al: Relationships between the children and parents for coronary risk factors. Pediatr Int, 2001; 43(6): 611-23
12. Kavey RW, Daniels SR, Lauer RM et al: American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood. Circulation, 2003; 107: 1562-6
13. Kelishadi R, Sarraf-Zadegan N, Naderi Gh et al: Atherosclerosis risk factors in children and adolescents with or without family history of premature coronary artery disease. Med Sci Monit, 2002; 8(6): 425-9
14. Kelishadi R, Alikhassy H, Amiri M: Zinc and copper status in children with high family risk of premature cardiovascular disease. Ann Saud Med, 2002; 22(5-6): 291-4
15. Kelishadi R, Naderi Gh, Asgary S: Oxidized-LDL metabolites with high family risk for premature cardiovascular disease. Ind J Ped, 2002; 69(9): 755-9
16. Asherson RA, Cervera R: 'Primary', 'Secondary' and other variants of the antiphospholipid syndrome. Lupus, 1994; 3: 293-8
17. Jaruowsk M, Dudek D: Successful coronary stent implantation in a patient with primary antiphospholipid syndrome. Blood - coagulation - Fibrinolysis, 1998; 9(8): 753-6
18. Wu R, Nityanand S, Berglund L et al: Antibodies against cardiololipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol, 1997; 17: 3159-63
19. Rosove MH, Brewer PMC: Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Ann Intern Med, 1992; 117: 303-8
20. Hamsten A, Norberg R, Bjorkhlom M et al: Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet, 1986; 1: 113-16
21. Raghavan C, Ditchfield J, Taylor RJ: Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction. J Clin Pathol, 1993; 46: 1113-6
22. Klemp P, Cooper RC, Strauss FJ et al: Anticardiolipin antibodies and ischemic heart disease. Clin Exp Immunol, 1998; 74(2): 254-7
23. Christensen K: Antiphospholipid antibodies and occlusive vascular disease, 1993; 155(37): 2896-900
24. Kaltwineel N: Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary anti-phospholipid syndrome. Ann Intern Med, 1999; 15(116): 974-6
25. Farsi A, Domeneghetti MP, Fedi S: High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease. Autoimmunity, 1999; 30: 93-7
26. Brey RL, Abbott RD, Curb JD et al: [beta]2-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The Honolulu Heart Program. Stroke, 2001; 32: 1701-6
27. Feriazzo B, Benanno D: Connection between heart disease and anticardiolipin antibody positivity: Minerva-Cardiol, 1993; 41(4): 13-7